COLFAX CORP (CFX) Stock Price, Forecast & Analysis

NYSE:CFX

39.06
-1.53 (-3.77%)
At close: Apr 4, 2022
39.06
0 (0%)
After Hours: 4/4/2022, 8:16:47 PM

CFX Key Statistics, Chart & Performance

Key Statistics
Market Cap6.10B
Revenue(TTM)3.85B
Net Income(TTM)71.68M
Shares156.25M
Float142.06M
52 Week High54.67
52 Week Low35.66
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)2.13
PE18.34
Fwd PE5.37
Earnings (Next)04-28
IPO2008-05-08
Sector
GICS SectorIndustrials
GICS IndustryMachinery
GICS IndustryGroupCapital Goods
CFX short term performance overview.The bars show the price performance of CFX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 -10 -15

CFX long term performance overview.The bars show the price performance of CFX in the last 1, 2 and 3 years. 1 year 2 years 3 years -2 -4 -6 -8 -10

The current stock price of CFX is 39.06 null. In the past month the price increased by 7.54%. In the past year, price decreased by -10.02%.

COLFAX CORP / CFX Daily stock chart

CFX Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to CFX. When comparing the yearly performance of all stocks, CFX is a bad performer in the overall market: 61.5% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
CFX Full Technical Analysis Report

CFX Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to CFX. CFX has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
CFX Full Fundamental Analysis Report

CFX Financial Highlights

Over the last trailing twelve months CFX reported a non-GAAP Earnings per Share(EPS) of 2.13. The EPS increased by 53.24% compared to the year before.


Industry RankSector Rank
PM (TTM) 1.86%
ROA 0.84%
ROE 1.55%
Debt/Equity 0.45
Chartmill High Growth Momentum
EPS Q2Q%15.69%
Sales Q2Q%23.57%
EPS 1Y (TTM)53.24%
Revenue 1Y (TTM)25.51%
CFX financials

CFX Forecast & Estimates

19 analysts have analysed CFX and the average price target is 51.43 null. This implies a price increase of 31.66% is expected in the next year compared to the current price of 39.06.

For the next year, analysts expect an EPS growth of 241.51% and a revenue growth 7.2% for CFX


Analysts
Analysts78.95
Price Target51.43 (31.67%)
EPS Next Y241.51%
Revenue Next Year7.2%
CFX Analyst EstimatesCFX Analyst Ratings

CFX Ownership

Ownership
Inst Owners0%
Ins Owners1.27%
Short Float %N/A
Short RatioN/A
CFX Ownership

CFX Competitors/Peers

The largest stocks on the US markets in the "Industrial Machinery & Supplies & Components" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
PH PARKER HANNIFIN CORP28.4125.664B
ITW ILLINOIS TOOL WORKS26.5486.47B
IR INGERSOLL-RAND INC26.6138.227B
SYM SYMBOTIC INC58.1335.167B
OTIS OTIS WORLDWIDE CORP20.5734.849B
DOV DOVER CORP22.0331.966B
XYL XYLEM INC22.7630.865B
SNA SNAP-ON INC18.6519.903B
FTV FORTIVE CORP19.5518.4B
RBC RBC BEARINGS INC41.117.408B

About CFX

Company Profile

CFX logo image Colfax Corp. operates as a diversified technology company. The company is headquartered in Wilmington, Delaware and currently employs 16,200 full-time employees. The company went IPO on 2008-05-08. The Company’s segments include Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. Its fabrication technology products are marketed under several brands, including ESAB. The Medical Technology segment develops, manufactures and distributes medical devices and services across the continuum of patient care from injury prevention to joint replacement to the rehabilitation after surgery, injury from degenerative disease, enabling people to regain or maintain their natural motion. Its products are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, athletic trainers and other healthcare professionals.

Company Info

COLFAX CORP

2711 Centerville Road, Suite 400

Wilmington DELAWARE 20701 US

CEO: Matthew L. Trerotola

Employees: 16200

CFX Company Website

Phone: 13022529160.0

COLFAX CORP / CFX FAQ

Can you describe the business of COLFAX CORP?

Colfax Corp. operates as a diversified technology company. The company is headquartered in Wilmington, Delaware and currently employs 16,200 full-time employees. The company went IPO on 2008-05-08. The Company’s segments include Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. Its fabrication technology products are marketed under several brands, including ESAB. The Medical Technology segment develops, manufactures and distributes medical devices and services across the continuum of patient care from injury prevention to joint replacement to the rehabilitation after surgery, injury from degenerative disease, enabling people to regain or maintain their natural motion. Its products are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, athletic trainers and other healthcare professionals.


What is the stock price of COLFAX CORP today?

The current stock price of CFX is 39.06 null. The price decreased by -3.77% in the last trading session.


Does COLFAX CORP pay dividends?

CFX does not pay a dividend.


What is the ChartMill technical and fundamental rating of CFX stock?

CFX has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Which stock exchange lists CFX stock?

CFX stock is listed on the New York Stock Exchange exchange.


How is the valuation of COLFAX CORP (CFX) based on its PE ratio?

The PE ratio for COLFAX CORP (CFX) is 18.34. This is based on the reported non-GAAP earnings per share of 2.13 and the current share price of 39.06 null.


Can you provide the market cap for COLFAX CORP?

COLFAX CORP (CFX) has a market capitalization of 6.10B null. This makes CFX a Mid Cap stock.